Varian's InSightive Analytics Solution Now Supports Multi-modality Treatment | Varian

{ "pageType": "news-article", "title": "Varian's InSightive Analytics Solution Now Supports Multi-modality Treatment", "articleDate": "September 19, 2016", "introText": "", "category": "Oncology" }

Varian's InSightive Analytics Solution Now Supports Multi-modality Treatment

PALO ALTO, Calif., Sept. 19, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the release of InSightiveTM analytics v1.2. The software solution can now support both radiation and medical oncology data analytics for more informed decision making. InSightive allows users to easily explore their clinical and operational data to uncover trends that may lead to improved outcomes.

InSightive analytics gives oncology care providers the ability to automate business intelligence by aggregating, structuring, and processing their data. Decision making is simplified through InSightive's collaborative user interfaces, which help transform static information into dynamic visualizations and smart, customizable dashboards. Additionally, using the enhanced functionality of the software, InSightive users can expand analytics-driven decision making from a single site to an entire cancer care network.

"InSightive is used by many different functional roles within our clinic and across our hospital network," said Garry Currie, head of Radiotherapy Physics at Beatson West of Scotland Cancer Centre in Glasgow, U.K. "It has helped us gain valuable awareness into our planning and treatment regimens, so we can provide better patient care, improving our effectiveness and efficiency." 

Customers can also take advantage of Varian's professional services to help them configure InSightive analytics to their workflows. At UCLA Health, Varian's clinical consulting team assessed clinical and operational workflows to identify areas for improved data capture and data quality, which led to greater organizational analytics adoption and a pathway to improved patient care. 

"Analytics has the power to transform raw data into actionable insights for cancer care providers," said Sukhveer Singh, vice president, Oncology Continuum Solutions, Varian Medical Systems. "It is revealing what was previously unknown and in doing so, improving the quality of care that can be provided to cancer patients. InSightive analytics brings us another step closer to our goal of living in a world without fear of cancer."

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, cables and connectors as well as image processing software and workstations for use in medical and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 7,700 people who are located at manufacturing sites in North America, Europe, and China and sales and support offices around the world.  For more information, visit or follow us on Twitter.

Forward-Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry or market outlook; the ability of the company's products to treat cancer or achieve certain results; and any statements using the terms "can," "will," "improve," "transform" and similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the demand for the company's products; the company's ability to develop, gain regulatory clearance or approval, commercialize, and deploy new and existing products; the company's ability to meet legal and regulatory requirements; changes in the legal or regulatory environment; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

Press Contact

Mark Plungy
Varian Medical Systems
+1 (650) 424-5630


SOURCE Varian Medical Systems